Results 141 to 150 of about 88,809 (304)

The Relationship Between Polycystic Ovary Syndrome (PCOS) and Depression

open access: yesClinical Endocrinology, EarlyView.
ABSTRACT Objective Polycystic ovary syndrome (PCOS) is a prevalent endocrine disorder, frequently accompanied by psychological comorbidities including depression. The aim of this narrative review is to summarise the latest research regarding potential contributors to and underpinning mechanisms of this relationship.
Asimina I. Karampela, Maralyn Druce
wiley   +1 more source

Relationship between body mass index and quality of life, use of dietary and physical activity self-management strategies, and mental health in individuals with polycystic ovary syndrome

open access: yesOpen Health
Polycystic ovary syndrome (PCOS) can negatively affect health and well-being. This study aimed to assess quality of life, use of self-management strategies, stress, anxiety, and depression in people with PCOS, and the effect of body mass index (BMI) on ...
Masters Melissa, Grevstad Nels
doaj   +1 more source

Inositol and Berberine Synergistically Reprogram Endocrine and Ovarian Metabolism in Polycystic Ovary Syndrome

open access: yesCell Proliferation, EarlyView.
In a DHEA+HFD‐induced mouse model, Ins/BBR alleviated mitochondrial defects and broadly reprogrammed metabolic landscape in granulosa cells, in specific, restoring nucleotide pools and amino acid turnover, and preventing abnormal long‐chain fatty acid accumulation.
Juan Ge   +8 more
wiley   +1 more source

A call to action: A consensus statement on knowledge gaps and research priorities on the management of women with early onset type 2 diabetes in the preconception, pregnancy and postnatal periods

open access: yesDiabetic Medicine, EarlyView.
Abstract Aims Research to inform, co‐develop and evaluate optimal care for women with early‐onset type 2 diabetes (EOT2D) before, during and after pregnancy is lacking. Informed by patient perspectives and the results of the James Lind Alliance priority‐setting partnership in diabetes in pregnancy, we aimed to develop a consensus statement to guide ...
Sara L. White   +8 more
wiley   +1 more source

Drospirenone and PCOS [PDF]

open access: yesJournal of Family Planning and Reproductive Health Care, 2005
openaire   +2 more sources

Providing holistic care for patients with metabolic dysfunction‐associated steatotic liver disease/metabolic dysfunction‐associated steatohepatitis: Key aspects of clinical assessment and how to develop individualised care plans for surveillance and interventions

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
Abstract Metabolic dysfunction‐associated steatotic liver disease (MASLD), characterised by hepatic steatosis and metabolic dysfunction (i.e., obesity, type 2 diabetes, dyslipidaemia, and hypertension), is affecting over 30% of the adult population worldwide.
Lanlan Chen, Paul Horn, Frank Tacke
wiley   +1 more source

Words do matter:A systematic review on how different terminology for the same condition influences management preferences [PDF]

open access: yes, 2017
Barratt, Alexandra L   +4 more
core   +2 more sources

Corrigendum: Gestational diabetes mellitus and polycystic ovary syndrome, a position statement from EGOI-PCOS

open access: yesFrontiers in Endocrinology
Paola Quaresima   +8 more
doaj   +1 more source

PCOS IVF [PDF]

open access: yesFertility and Sterility, 2018
L.G. Cooney   +7 more
openaire   +1 more source

Healthcare Resource Utilisation and Cost of Obesity and Related Complications in the United States: A Systematic Literature Review

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aim Obesity is an increasingly prevalent, chronic, heterogeneous disease, associated with a variety of obesity‐related complications (ORCs). This systematic literature review assessed US healthcare resource utilisation (HCRU) and costs (direct and indirect) for people living with obesity (PwO) or overweight and ORCs.
Jaime P. Almandoz   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy